Is RSLBF or QYLD a better dividend investment in 2026?

RSLBF currently yields 1.37% with a 5% 5-year dividend growth rate. QYLD yields 11.92% with -2.1% growth. The better choice depends on your goal: QYLD offers higher current income.

What is the dividend yield difference between RSLBF and QYLD?

RSLBF has a forward dividend yield of 1.37% ($0.31/share annually). QYLD yields 11.92% ($2.04/share annually). The yield gap is 10.55 percentage points.

Home › Compare › RSLBF vs QYLD

RSLBF vs QYLD: Dividend Comparison 2026

RSLBF yields 1.37% · QYLD yields 11.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 QYLD wins by $3.8K in total portfolio value· pulled ahead in Year 9

INVESTMENT

TIME HORIZON10 years

RSLBF

● Live price

1.37%

Share price

$23.00

Annual div

$0.31

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$21.6K

Annual income

$149.57

Full RSLBF calculator →

QYLD

Global X Nasdaq 100 Covered Call ETF

● Live price

11.92%

Share price

$17.15

Annual div

$2.04

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.4K

Annual income

$5,659.31

Full QYLD calculator →

Portfolio growth — RSLBF vs QYLD

📍 QYLD pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	RSLBF	QYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, RSLBF + QYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

RSLBF pays

QYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RSLBF

Annual income on $10K today (after 15% tax)

$116.34/yr

After 10yr DRIP, annual income (after tax)

$127.13/yr

QYLD

Annual income on $10K today (after 15% tax)

$1,013.51/yr

After 10yr DRIP, annual income (after tax)

$4,810.41/yr

At 15% tax rate, QYLD beats the other by $4,683.28/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RSLBF + QYLD for your $10,000?

RSLBF: 50%QYLD: 50%

100% QYLD50/50100% RSLBF

Portfolio after 10yr

$23.5K

Annual income

$2,904.44/yr

Blended yield

12.35%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RSLBF buys

QYLD buys

No recent congressional trades found for RSLBF or QYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricRSLBFQYLD

Forward yield	1.37%	11.92% ✓
Annual dividend / share	$0.31	$2.04 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$21.6K	$25.4K ✓
Annual income after 10y	$149.57	$5,659.31 ✓
Total dividends collected	$1.4K	$27.1K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: RSLBF vs QYLD ($10,000, DRIP)

Year	RSLBF Portfolio	RSLBF Income/yr	QYLD Portfolio	QYLD Income/yr	Gap
1	$10,837	$136.87	$10,352	$1,192.36	+$485.00 → RSLBF
2	$11,734	$138.62	$10,830	$1,347.57	+$904.00 → RSLBF
3	$12,696	$140.28	$11,460	$1,539.07	+$1.2K → RSLBF
4	$13,726	$141.84	$12,275	$1,777.84	+$1.5K → RSLBF
5	$14,830	$143.33	$13,323	$2,078.95	+$1.5K → RSLBF
6	$16,013	$144.72	$14,667	$2,463.34	+$1.3K → RSLBF
7	$17,280	$146.04	$16,396	$2,960.57	+$884.00 → RSLBF
8	$18,637	$147.29	$18,631	$3,612.97	+$6.00 → RSLBF
9← crossover	$20,090	$148.46	$21,548	$4,482.15	$1.5K → QYLD
10	$21,646	$149.57	$25,398	$5,659.31	$3.8K → QYLD

RSLBF vs QYLD: Complete Analysis 2026

RSLBF — Stock

RaySearch Laboratories AB (publ), a medical technology company, develops software solutions for cancer treatment worldwide. It develops and markets RayStation, a treatment planning system for treatment activities, such as automated planning, adaptive therapy, multi-criteria optimization, fast and accurate dose computations, OAR dose reduction, robustness, machine learning, VMAT, IMRT, 3D-CRT, virtual simulation, electron beam therapy, tomotherapy, stereotactic, proton therapy, carbon ion therapy, and boron neutron capture therapy. The company also develops RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, tomotherapy, and electron beam radiation therapy; and RayCare, an oncology information system to support cancer treatment activities. In addition, it offers RayCommand, a treatment control system that is compatible with various hardware models and supports advanced functionalities of treatment machines and software systems; and RayIntelligence, a cloud-based oncology analytics system that turns patient data into insights. Further, the company provides training courses related to its products. RaySearch Laboratories AB (publ) is headquartered in Stockholm, Sweden.

Full RSLBF Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →

📬

Get this RSLBF vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RSLBF vs SCHD RSLBF vs JEPI RSLBF vs O RSLBF vs KO RSLBF vs MAIN RSLBF vs XYLD RSLBF vs JEPQ RSLBF vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.